- Home
- AGX vs VCEL Comparison
AGX vs VCEL Comparison
Compare AGX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGX
- VCEL
- Stock Information
- Founded
- AGX 1961
- VCEL 1989
- Country
- AGX United States
- VCEL United States
- Employees
- AGX N/A
- VCEL N/A
- Industry
- AGX Engineering & Construction
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AGX Consumer Discretionary
- VCEL Health Care
- Exchange
- AGX Nasdaq
- VCEL Nasdaq
- Market Cap
- AGX 1.9B
- VCEL 2.1B
- IPO Year
- AGX N/A
- VCEL 1997
- Fundamental
- Price
- AGX $151.47
- VCEL $39.73
- Analyst Decision
- AGX Buy
- VCEL Strong Buy
- Analyst Count
- AGX 2
- VCEL 8
- Target Price
- AGX $150.00
- VCEL $61.75
- AVG Volume (30 Days)
- AGX 506.5K
- VCEL 548.6K
- Earning Date
- AGX 06-05-2025
- VCEL 05-08-2025
- Dividend Yield
- AGX 1.01%
- VCEL N/A
- EPS Growth
- AGX 157.32
- VCEL N/A
- EPS
- AGX 6.15
- VCEL 0.20
- Revenue
- AGX $874,179,000.00
- VCEL $237,224,000.00
- Revenue This Year
- AGX $10.41
- VCEL $23.23
- Revenue Next Year
- AGX $18.32
- VCEL $24.41
- P/E Ratio
- AGX $24.17
- VCEL $198.70
- Revenue Growth
- AGX 52.47
- VCEL 20.10
- 52 Week Low
- AGX $60.03
- VCEL $37.76
- 52 Week High
- AGX $191.46
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- AGX 59.56
- VCEL 39.07
- Support Level
- AGX $126.07
- VCEL $39.32
- Resistance Level
- AGX $154.10
- VCEL $42.02
- Average True Range (ATR)
- AGX 10.65
- VCEL 2.56
- MACD
- AGX 0.98
- VCEL 0.17
- Stochastic Oscillator
- AGX 93.47
- VCEL 28.80
About AGX Argan Inc.
Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.